MSB 1.01% 98.0¢ mesoblast limited

Multisystem Inflammatory Syndrome in Children (MIS-C), page-124

  1. 81 Posts.

    It makes me as a Long Term Holder wonder just why the Australian media don't demonstrate some consistent interest and genuine enthusiasm in getting behind Mesoblast and all that this Australian Company offers to globally benefit man-kind . Here we are on the cusp of learning the results of several major trials ( be they positive or negative) the results will be a story worth telling . But I won't hold my breath!
    Perhaps it doesn't meet their agendas, perhaps they don't understand....or perhaps it's just "The Tall Poppy" syndrome at work again.

    It's time they got off their shiny back-sides, did some research and showed us exactly what real journalism is about. Facts...not opinions!



 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
98.0¢
Change
-0.010(1.01%)
Mkt cap ! $1.118B
Open High Low Value Volume
99.5¢ $1.02 97.0¢ $2.821M 2.832M

Buyers (Bids)

No. Vol. Price($)
1 20688 97.5¢
 

Sellers (Offers)

Price($) Vol. No.
99.0¢ 35000 3
View Market Depth
Last trade - 16.10pm 15/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.